Abstract  The neurotoxic effects of organic solvents are reviewed. Organic solvents have been used in extraction, dissolution or suspension of fats, waxes and resins. Studies have shown that acute neurotoxicity is similar for human and laboratory animal exposures and is characterized by narcosis, anesthesia, central nervous system depression, respiratory arrest, loss of consciousness and death. Chronic effects have been studied to a limited extent in animals and have been documented epidemiologically for workers and solvent abusers. Reported effects included peripheral neuropathy and mild toxic encephalopathy. Three severity levels were defined for chronic human exposures: minimal, organic affective syndrome; moderate, mild, chronic toxic encephalopathy; and pronounced, severe, chronic toxic encephalopathy. Neurophysiological effects (electromyogram or electroencephalogram abnormalities, decreased nerve conduction velocities) have also been reported in exposed workers. Neurobehavioral effects such as reversible subjective symptoms, prolonged personality or mood changes and intellectual impairment have been studied epidemiologically and in volunteers. Severe exposure has produced irreversible impairment of intellect and memory (dementia) and structural central nervous system damage. Metabolic aspects of organic solvent exposure were discussed. Guidelines for minimizing worker exposure are discussed in relation to exposure monitoring; control of exposure through contaminant control, worker isolation, use of personal protective equipment and worker education; and medical surveillance. A table containing a summary of NIOSH recommended exposure limits for organic solvents is presented. Examples of solvents neurotoxic to humans discussed include carbon-disulfide (75150), n-hexane (110543), methyl-n-butyl-ketone (591786), trichloroethylene (79016), perchloroethylene (127184) and toluene (108883)

Abstract  This document provides a preliminary public summary of available information collected by EPA’s Office of Pollution Prevention and Toxics (OPPT) in the Office of Chemical Safety and Pollution Prevention (OCSPP) on the manufacturing (including importing), processing, distribution in commerce, use, and disposal of this chemical. This is based on existing data available to EPA, including information collected under the Chemical Data Reporting rule, Toxics Release Inventory (if available), information from other Agency databases, other U.S. Government agencies, publicly available information from states, and a review of published literature. In addition, the document includes information reported to EPA by producers and users of the chemical in the United States and in other countries. This preliminary use information and any additional use information received in the docket by March 15, 2017 will inform efforts to develop the scope of the chemical risk evaluation required under section 6(b)(4) of the Toxic Substances Control Act, and will inform any risk management efforts following risk evaluation. Mention of trade names in this document does not constitute endorsement by EPA. To verify products or articles containing this chemical currently in commerce, EPA has identified several examples. Any lists are provided for informational purposes only. EPA and its employees do not endorse any of the products or companies. This document does not contain confidential business information (CBI).